
Cytonics Selects CARA Life Sciences Platform for Rapid eTMF System Implementation
Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences